Decheng Capital LLC
- SEC CIK
- 0002010850
- Latest filing
- Aug 14, 2026
Holdings in Q2 2024
Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.
- Positions
- 24
- +2 vs. Q1 2024
- Portfolio value
- $326.3M
- −$419.3M (−56.2%) vs. Q1 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CGONCG Oncology, Inc. | COM | 5,458,810 | $172.3M | 52.8% | 00.0% | Unchanged | History |
| NUVBNuvation Bio Inc. | COM CL A | 6,950,239 | $20.3M | 6.2% | +6,950,239 | New | History |
| RCUSArcus Biosciences, Inc. | COM | 869,790 | $13.2M | 4.1% | 00.0% | Unchanged | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 3,070,442 | $12.6M | 3.8% | +970,859+46.2% | Added | History |
| KRYSKrystal Biotech, Inc. | COM | 65,772 | $12.1M | 3.7% | 00.0% | Unchanged | History |
| BYSIBeyondSpring Inc. | SHS | 4,958,143 | $11.9M | 3.6% | 00.0% | Unchanged | History |
| ILMNIllumina, Inc. | COM | 108,767 | $11.4M | 3.5% | −20,300−15.7% | Reduced | History |
| MRUSMerus N.V. | COM | 179,098 | $10.6M | 3.2% | +77,300+75.9% | Added | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 850,000 | $8.76M | 2.7% | 00.0% | Unchanged | History |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 400,000 | $7.68M | 2.4% | +400,000 | New | History |
| MLTXMoonLake Immunotherapeutics | COM CL A | 166,600 | $7.33M | 2.2% | 00.0% | Unchanged | History |
| FDMT4D Molecular Therapeutics, Inc. | COM | 347,835 | $7.30M | 2.2% | 00.0% | Unchanged | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 157,958 | $7.07M | 2.2% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 94,043 | $5.10M | 1.6% | 00.0% | Unchanged | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 98,558 | $4.37M | 1.3% | +12,195+14.1% | Added | History |
| AURAAura Biosciences, Inc. | COM | 515,555 | $3.90M | 1.2% | 00.0% | Unchanged | History |
| EQEquillium, Inc. | COM | 4,447,308 | $3.08M | 0.9% | 00.0% | Unchanged | History |
| WGSGeneDx Holdings Corp. | COM CL A | 103,604 | $2.71M | 0.8% | 00.0% | Unchanged | History |
| VERAVera Therapeutics, Inc. | CL A | 69,767 | $2.52M | 0.8% | +69,767 | New | History |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 326,810 | $1.08M | 0.3% | 00.0% | Unchanged | History |
| ATRCAtriCure, Inc. | COM | 26,797 | $610.2K | 0.2% | 00.0% | Unchanged | History |
| GRALGRAIL, Inc. | COM | 18,127 | $278.6K | 0.1% | +18,127 | New | History |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 646,057 | $103.4K | <0.1% | +646,057 | New | – |
| ACLXArcellx, Inc. | COMMON STOCK | 1,177 | $65.0K | <0.1% | +1,177 | New | History |
Sold out since Q1 2024 (4)
Positions held at the end of Q1 2024 that are gone from this filing.
| Security | Class | Shares in Q1 2024 | Value in Q1 2024 | % of portfolio in Q1 2024 | History |
|---|---|---|---|---|---|
| ALPNAlpine Immune Sciences, Inc. | COM | 8,317,924 | $329.7M | 44.2% | History |
| TXG10x Genomics, Inc. | CL A COM | 195,835 | $7.35M | 1.0% | History |
| HLTHCue Health Inc. | COM | 8,980,909 | $1.70M | 0.2% | History |
| WHWKWhitehawk Therapeutics, Inc. | COM | 526,329 | $1.23M | 0.2% | History |